Escherichia Coli Infections
📧 Sign up to get email alerts when something new happens for Escherichia Coli Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients [Phase 2, Phase 3]
Phase 2/3 trial updates on sitafloxacin and ertapenem for acute urinary tract infections due to E. coli or Klebsiella in post-kidney transpl…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Vaccine Against Escherichia Coli Infection [Phase 1]
Phase 1 trial update for a vaccine targeting Escherichia coli infections. The study has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Community - Associated Extended-spectrum Beta-lactamases (ESBL)
This clinical trial update reports the completion of a community-based study on ESBL-producing bacterial infections, involving Escherichia c…
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli [Phase 2]
A Phase 2 clinical trial update evaluating the combination of sitafloxacin and ertapenem for acute pyelonephritis caused by Escherichia coli…
-
CLINICAL_TRIALS trial_result · 2007-03-15Clinical Trial Update: Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units
Clinical trial update on piperacillin-tazobactam for various bacterial infections in hematology/oncology units has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.